Regulation of dendritic cell function through Toll-like receptors
- PMID: 12776992
- DOI: 10.2174/1566524033479726
Regulation of dendritic cell function through Toll-like receptors
Abstract
Higher animals establish host defense by orchestrating innate and adaptive immunity. This is mediated by professional antigen presenting cells, i.e. dendritic cells (DCs). DCs can incorporate pathogens, produce a variety of cytokines, maturate, and present pathogen-derived peptides to T cells, thereby inducing T cell activation and differentiation. These responses are triggered by microbial recognition through type I transmembrane proteins, Toll-like receptors (TLRs) on DCs. TLRs consist of ten members and each TLR is involved in recognizing a variety of microorganism-derived molecular structures. TLR ligands include cell wall components, proteins, nucleic acids, and synthetic chemical compounds, all of which can activate DCs as immune adjuvants. Each TLR can activate DCs in a similar, but distinct manner. For example, TLRs can be divided into subgroups according to their type I interferon (IFN) inducing ability. TLR2 cannot induce IFN-alpha or IFN-beta, but TLR4 can lead to IFN-beta production. Meanwhile, TLR3, TLR7, and TLR9 can induce both IFN-alpha and IFN-beta. Recent evidences suggest that cytoplamic adapters for TLRs are especially crucial for this functional heterogeneity. Clarifying how DC function is regulated by TLRs should provide us with critical information for manipulating the host defense against a variety of diseases.
Similar articles
-
Regulation of dendritic cell function through toll-like receptors.Curr Mol Med. 2003 Dec;3(8):759-71. doi: 10.2174/1566524033479366. Curr Mol Med. 2003. PMID: 14682496 Review.
-
Toll-like receptors as adjuvant receptors.Biochim Biophys Acta. 2002 Feb 13;1589(1):1-13. doi: 10.1016/s0167-4889(01)00182-3. Biochim Biophys Acta. 2002. PMID: 11909637 Review.
-
Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.J Immunol. 2003 Oct 15;171(8):4320-8. doi: 10.4049/jimmunol.171.8.4320. J Immunol. 2003. PMID: 14530357
-
IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.J Immunol. 2005 Feb 15;174(4):1932-7. doi: 10.4049/jimmunol.174.4.1932. J Immunol. 2005. PMID: 15699120
-
IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells.J Immunol. 2004 Dec 15;173(12):7548-55. doi: 10.4049/jimmunol.173.12.7548. J Immunol. 2004. PMID: 15585882
Cited by
-
Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome.Clin Vaccine Immunol. 2007 Nov;14(11):1499-504. doi: 10.1128/CVI.00153-07. Epub 2007 Aug 22. Clin Vaccine Immunol. 2007. PMID: 17715328 Free PMC article.
-
MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands.J Virol. 2007 Aug;81(15):8180-91. doi: 10.1128/JVI.00421-07. Epub 2007 May 16. J Virol. 2007. PMID: 17507480 Free PMC article.
-
How to Naturally Support the Immune System in Inflammation-Essential Oils as Immune Boosters.Biomedicines. 2023 Aug 25;11(9):2381. doi: 10.3390/biomedicines11092381. Biomedicines. 2023. PMID: 37760822 Free PMC article. Review.
-
Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis.Respir Res. 2005 Sep 7;6(1):100. doi: 10.1186/1465-9921-6-100. Respir Res. 2005. PMID: 16146574 Free PMC article. Clinical Trial.
-
Total parenteral-nutrition-mediated dendritic-cell activation and infiltration into the small intestine in a rat model.J Anesth. 2011 Feb;25(1):57-64. doi: 10.1007/s00540-010-1037-8. Epub 2010 Nov 6. J Anesth. 2011. PMID: 21057821
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources